Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 14 results.
User Information
Export Records
  1. 1.   Effect of Calcium Carbonate Encapsulation on the Activity of Orally Administered CpG Oligonucleotides
  2. Kayraklioglu, Neslihan; Scheiermann, Julia; Alvord, W. Gregory; Klinman, Dennis
  3. MOLECULAR THERAPY-NUCLEIC ACIDS. 2017, Sep 15; 8: 243-249.
  1. 2.   Intratumoral Injection of CpG Oligonucleotides Induces the Differentiation and Reduces the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells
  2. Shirota, Y.; Shirota, H.; Klinman, D. M.
  3. Journal of Immunology. 2012, Feb; 188(4): 1592-1599.
  1. 3.   The acceleration of wound healing in primates by the local administration of immunostimulatory CpG oligonucleotides
  2. Yamamoto, M.; Sato, T.; Beren, J.; Verthelyi, D.; Klinman, D. M.
  3. Biomaterials. 2011, Jun; 32(18): 4238-4242.
  1. 4.   CpG-conjugated apoptotic tumor cells elicit potent tumor-specific immunity
  2. Shirota, H.; Klinman, D. M.
  3. Cancer Immunology Immunotherapy. 2011, May; 60(5): 659-669.
  1. 5.   CpG DNA as a vaccine adjuvant
  2. Bode, C.; Zhao, G.; Steinhagen, F.; Kinjo, T.; Klinman, D. M.
  3. Expert Review of Vaccines. 2011, Apr; 10(4): 499-511.
  1. 6.   Short- and long-term changes in gene expression mediated by the activation of TLR9
  2. Klaschik, S.; Tross, D.; Shirota, H.; Klinman, D. M.
  3. Molecular Immunology. 2010, Mar; 47(6): 1317-1324.
  1. 7.   Immunostimulatory CpG oligonucleotides: Effect on gene expression and utility as vaccine adjuvants
  2. Klinman, D. M.; Klaschik, S.; Tomaru, K.; Shirota, H.; Tross, D.; Ikeuchi, H.
  3. Vaccine. 2010, Feb; 28(8): 1919-1923.
  1. 8.   Accelerated wound healing mediated by activation of Toll-like receptor 9
  2. Sato, T.; Yamamoto, M.; Shimosato, T.; Klinman, D. M.
  3. Wound Repair and Regeneration. 2010, Nov-Dec; 18(6): 586-593.
  1. 9.   Global changes in gene expression and synergistic interactions induced by TLR9 and TLR3
  2. Tross, D.; Petrenko, L.; Klaschik, S.; Zhu, Q.; Klinman, D. M.
  3. Molecular Immunology. 2009 46(13): 2557-2564.
  1. 10.   Effect of CpG oligonucleotides on vaccine-induced B cell memory
  2. Tross, D.; Klinman, D. M.
  3. Journal of Immunology. 2008 181(8): 5785-5790.
  1. 11.   CpG-containing oligodeoxynucleotide promotes microglial cell uptake of amyloid beta 1-42 peptide by up-regulating the expression of the G-protein-coupled receptor mFPR2
  2. Iribarren, P.; Chen, K. Q.; Hu, J. Y.; Gong, W. H.; Cho, E. H.; Lockett, S.; Uranchimeg, B.; Wang, J. M.
  3. Faseb Journal. 2005, OCT; 19(12): Published as FJ Express article on October 11, 2005.
  1. 12.   CpG oligodeoxynucleotides improve the response to hepatitis B immunization in healthy and SIV-infected rhesus macaques
  2. Verthelyi, D.; Wang, V. W.; Lifson, J. D.; Klinman, D. M.
  3. Aids. 2004 18(7): 1003-1008.
  1. 13.   CpG oligodeoxynucleotides protect normal and SIV-infected macaques from Leishmania infection
  2. Verthelyi, D.; Gursel, M.; Kenney, R. T.; Lifson, J. D.; Liu, S. Y.; Mican, J.; Klinman, D. M.
  3. Journal of Immunology. 2003 170(9): 4717-4723.
  1. 14.   CpG Oligodeoxynucleotides as Adjuvants for Clinical Use
  2. Shirota, H.; Klinman, Dennis
  3. 2017; (Immunopotentiators in Modern Vaccines, 2nd Edition): 163-198.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel